Home LiteratureArticle Details
PMID: 2966200 Published · ppublish English Journal Article

Mechanism of protection from graft-vs-host disease in murine mixed allogeneic chimeras. I. Development of a null cell population suppressive of cell-mediated lympholysis responses and derived from the syngeneic bone marrow component.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 140 ·No. 9 ·1988-05-01 ·Pages 2903-11

Sykes M, Eisenthal A, Sachs DH

Abstract

Splenocyte populations from whole body-irradiated recipients of mixed T cell-depleted (TCD) syngeneic and allogeneic (complete H-2 disparity) bone marrow, or of TCD syngeneic marrow alone, contain cells with the ability to suppress the generation of cell-mediated lympholysis responses in vitro. This activity, which is present by 8 days after bone marrow transplantation and persists for several weeks, has been analyzed for possible veto-like or other specificity. Although reproducible patterns of suppression were observed, depending both on host strain and on the genetic combination of the response examined, the overall suppression in vitro most closely resembles that which has been ascribed to "natural suppressor" cells in other systems. The suppression appears to be mediated by a non-T cell, non-B cell, nonadherent, asialo GM1-negative population. Cold target inhibition and CTL activity of chimeric cells have been ruled out as factors contributing to the observed suppression. Significantly, in mixed chimeras, suppression was found to be mediated exclusively by cells which were syngeneic to the recipient in both recipient strains tested. The rapid development of this suppressive activity may explain the resistance to graft-vs-host disease conferred on whole body-irradiated mice by the addition of TCD syngeneic marrow to an allogeneic graft-vs-host disease-producing inoculum.

MeSH Terms
Animals Bone Marrow/immunology,radiation effects Bone Marrow Transplantation Cell Adhesion Cytotoxicity, Immunologic Graft vs Host Disease/immunology Histocompatibility Antigens Class II/analysis Immune Tolerance Immunity, Cellular Killer Cells, Natural/immunology Major Histocompatibility Complex Mice Mice, Inbred Strains Radiation Chimera T-Lymphocytes, Regulatory/immunology
Chemicals
Histocompatibility Antigens Class II
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Sykes M
Immunology Branch, National Cancer Institute, Bethesda, MD 20892.
Eisenthal A
Sachs D H
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1988-05-01
Pages
2903-11
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com